246 related articles for article (PubMed ID: 30250137)
1. Integrative metabolic and transcriptomic profiling of prostate cancer tissue containing reactive stroma.
Andersen MK; Rise K; Giskeødegård GF; Richardsen E; Bertilsson H; Størkersen Ø; Bathen TF; Rye M; Tessem MB
Sci Rep; 2018 Sep; 8(1):14269. PubMed ID: 30250137
[TBL] [Abstract][Full Text] [Related]
2. Asporin is a stromally expressed marker associated with prostate cancer progression.
Rochette A; Boufaied N; Scarlata E; Hamel L; Brimo F; Whitaker HC; Ramos-Montoya A; Neal DE; Dragomir A; Aprikian A; Chevalier S; Thomson AA
Br J Cancer; 2017 Mar; 116(6):775-784. PubMed ID: 28152543
[TBL] [Abstract][Full Text] [Related]
3. Genes upregulated in prostate cancer reactive stroma promote prostate cancer progression in vivo.
Dakhova O; Rowley D; Ittmann M
Clin Cancer Res; 2014 Jan; 20(1):100-9. PubMed ID: 24150235
[TBL] [Abstract][Full Text] [Related]
4. Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling.
Tuxhorn JA; Ayala GE; Smith MJ; Smith VC; Dang TD; Rowley DR
Clin Cancer Res; 2002 Sep; 8(9):2912-23. PubMed ID: 12231536
[TBL] [Abstract][Full Text] [Related]
5. Stromal response to prostate cancer: nanotechnology-based detection of thioredoxin-interacting protein partners distinguishes prostate cancer associated stroma from that of benign prostatic hyperplasia.
Singer E; Linehan J; Babilonia G; Imam SA; Smith D; Loera S; Wilson T; Smith S
PLoS One; 2013; 8(6):e60562. PubMed ID: 23762225
[TBL] [Abstract][Full Text] [Related]
6. The Prostate Stromal Transcriptome in Aggressive and Lethal Prostate Cancer.
Ma C; Zhou Y; Fanelli GN; Stopsack KH; Fiorentino M; Zadra G; Mucci LA; Loda M; Tyekucheva S; Penney KL
Mol Cancer Res; 2023 Mar; 21(3):253-260. PubMed ID: 36511902
[TBL] [Abstract][Full Text] [Related]
7. A novel non-canonical Wnt signature for prostate cancer aggressiveness.
Sandsmark E; Hansen AF; Selnæs KM; Bertilsson H; Bofin AM; Wright AJ; Viset T; Richardsen E; Drabløs F; Bathen TF; Tessem MB; Rye MB
Oncotarget; 2017 Feb; 8(6):9572-9586. PubMed ID: 28030815
[TBL] [Abstract][Full Text] [Related]
8. High expression of PDGFR-β in prostate cancer stroma is independently associated with clinical and biochemical prostate cancer recurrence.
Nordby Y; Richardsen E; Rakaee M; Ness N; Donnem T; Patel HR; Busund LT; Bremnes RM; Andersen S
Sci Rep; 2017 Feb; 7():43378. PubMed ID: 28233816
[TBL] [Abstract][Full Text] [Related]
9. Development of a predictive model for stromal content in prostate cancer samples to improve signature performance.
Boufaied N; Takhar M; Nash C; Erho N; Bismar TA; Davicioni E; Thomson AA
J Pathol; 2019 Dec; 249(4):411-424. PubMed ID: 31206668
[TBL] [Abstract][Full Text] [Related]
10. Adenocarcinoma on needle prostatic biopsies: does reactive stroma predicts biochemical recurrence in patients following radical prostatectomy?
Billis A; Meirelles L; Freitas LL; Polidoro AS; Fernandes HA; Padilha MM; Magna LA; Reis LO; Ferreira U
Int Braz J Urol; 2013; 39(3):320-7. PubMed ID: 23849565
[TBL] [Abstract][Full Text] [Related]
11. Stromal expression of VEGF-A and VEGFR-2 in prostate tissue is associated with biochemical and clinical recurrence after radical prostatectomy.
Nordby Y; Andersen S; Richardsen E; Ness N; Al-Saad S; Melbø-Jørgensen C; Patel HR; Dønnem T; Busund LT; Bremnes RM
Prostate; 2015 Nov; 75(15):1682-93. PubMed ID: 26268996
[TBL] [Abstract][Full Text] [Related]
12. Association between bivariate expression of key oncogenes and metabolic phenotypes of patients with prostate cancer.
Khodayari Moez E; Pyne S; Dinu I
Comput Biol Med; 2018 Dec; 103():55-63. PubMed ID: 30340213
[TBL] [Abstract][Full Text] [Related]
13. High BIRC7 Expression Might Be an Independent Prognostic Indicator of Poor Recurrence-Free Survival in Patients With Prostate Cancer.
Yang Y; Sun P; Xu W; Xia W
Technol Cancer Res Treat; 2018 Jan; 17():1533033818809694. PubMed ID: 30376767
[TBL] [Abstract][Full Text] [Related]
14. Spatial maps of prostate cancer transcriptomes reveal an unexplored landscape of heterogeneity.
Berglund E; Maaskola J; Schultz N; Friedrich S; Marklund M; Bergenstråhle J; Tarish F; Tanoglidi A; Vickovic S; Larsson L; Salmén F; Ogris C; Wallenborg K; Lagergren J; Ståhl P; Sonnhammer E; Helleday T; Lundeberg J
Nat Commun; 2018 Jun; 9(1):2419. PubMed ID: 29925878
[TBL] [Abstract][Full Text] [Related]
15. Changes in gene transcription underlying the aberrant citrate and choline metabolism in human prostate cancer samples.
Bertilsson H; Tessem MB; Flatberg A; Viset T; Gribbestad I; Angelsen A; Halgunset J
Clin Cancer Res; 2012 Jun; 18(12):3261-9. PubMed ID: 22510345
[TBL] [Abstract][Full Text] [Related]
16. Protease-activated receptor-1 is upregulated in reactive stroma of primary prostate cancer and bone metastasis.
Zhang X; Wang W; True LD; Vessella RL; Takayama TK
Prostate; 2009 May; 69(7):727-36. PubMed ID: 19170048
[TBL] [Abstract][Full Text] [Related]
17. Extracellular matrix secreted by reactive stroma is a main inducer of pro-tumorigenic features on LNCaP prostate cancer cells.
Palumbo A; Ferreira LB; Reis de Souza PA; Oliveira FL; Pontes B; Viana NB; Machado DE; Palmero CY; Alves LM; Gimba ER; Nasciutti LE
Cancer Lett; 2012 Aug; 321(1):55-64. PubMed ID: 22388175
[TBL] [Abstract][Full Text] [Related]
18. Stromal and epithelial transcriptional map of initiation progression and metastatic potential of human prostate cancer.
Tyekucheva S; Bowden M; Bango C; Giunchi F; Huang Y; Zhou C; Bondi A; Lis R; Van Hemelrijck M; Andrén O; Andersson SO; Watson RW; Pennington S; Finn SP; Martin NE; Stampfer MJ; Parmigiani G; Penney KL; Fiorentino M; Mucci LA; Loda M
Nat Commun; 2017 Sep; 8(1):420. PubMed ID: 28871082
[TBL] [Abstract][Full Text] [Related]
19. Characterization of reactive stroma in prostate cancer: involvement of growth factors, metalloproteinase matrix, sexual hormones receptors and prostatic stem cells.
Silva MM; Matheus WE; Garcia PV; Stopiglia RM; Billis A; Ferreira U; Fávaro WJ
Int Braz J Urol; 2015; 41(5):849-58. PubMed ID: 26689510
[TBL] [Abstract][Full Text] [Related]
20. Expression of two WFDC1/ps20 isoforms in prostate stromal cells induces paracrine apoptosis through regulation of PTGS2/COX-2.
Hickman OJ; Smith RA; Dasgupta P; Rao SN; Nayak S; Sreenivasan S; Vyakarnam A; Galustian C
Br J Cancer; 2016 May; 114(11):1235-42. PubMed ID: 27115470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
